Free Trial

NortonLifeLock (NLOK) Financials

NortonLifeLock logo
$24.55 -0.05 (-0.20%)
As of 05/28/2026
Annual Income Statements for NortonLifeLock

Annual Income Statements for NortonLifeLock

This table shows NortonLifeLock's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Period end date 4/1/2016 3/31/2017 3/30/2018 3/29/2019 4/3/2020 4/2/2021 4/1/2022 3/31/2023 3/29/2024 3/28/2025 4/3/2026
Net Income / (Loss) Attributable to Common Shareholders
2,488 -106 1,138 31 3,887 554 836 1,334 607 643 973
Consolidated Net Income / (Loss)
2,488 -106 1,138 31 3,887 554 836 1,334 607 643 973
Net Income / (Loss) Continuing Operations
-821 -236 964 -110 578 696 836 1,334 607 643 973
Total Pre-Tax Income
392 -262 244 -107 819 872 1,042 783 447 1,029 1,511
Total Operating Income
457 -100 -154 158 355 896 1,005 1,206 1,110 1,610 2,120
Total Gross Profit
2,985 3,166 2,096 2,001 2,097 2,189 2,388 2,728 3,069 3,159 3,923
Total Revenue
3,600 4,019 2,559 2,456 2,490 2,551 2,796 3,317 3,800 3,935 5,000
Operating Revenue
3,600 4,019 2,559 2,456 2,490 2,551 2,796 3,317 3,800 3,935 5,000
Total Cost of Revenue
615 853 463 455 393 362 408 589 731 776 1,077
Operating Cost of Revenue
615 853 463 455 393 362 408 589 731 776 1,077
Total Operating Expenses
2,528 3,266 2,250 1,843 1,742 1,293 1,383 1,522 1,959 1,549 1,803
Selling, General & Admin Expense
295 564 487 410 368 215 392 286 604 291 -87
Marketing Expense
1,292 1,459 841 712 701 576 622 682 733 745 1,228
Research & Development Expense
748 823 455 420 328 267 253 313 332 329 409
Amortization Expense
57 147 87 80 79 74 85 172 233 174 218
Impairment Charge
- - - - - - - 0.00 0.00 3.00 0.00
Restructuring Charge
136 273 380 221 266 161 31 69 57 7.00 35
Total Other Income / (Expense), net
-65 -162 398 -265 464 -24 37 -423 -663 -581 -609
Interest Expense
75 208 256 208 196 144 126 401 669 578 569
Other Income / (Expense), net
10 46 654 -57 660 120 163 -22 6.00 -3.00 -40
Income Tax Expense
1,213 -26 -720 3.00 241 176 206 -551 -160 386 538
Basic Earnings per Share
$3.71 ($0.17) $1.85 $0.05 $6.32 $0.94 $1.44 $2.17 $0.95 $1.04 $1.59
Weighted Average Basic Shares Outstanding
670M 618M 616M 632M 615M 589M 581M 614M 637M 617M 612M
Diluted Earnings per Share
$3.71 ($0.17) $1.70 $0.05 $6.05 $0.92 $1.41 $2.14 $0.95 $1.03 $1.57
Weighted Average Diluted Shares Outstanding
670M 618M 668M 632M 643M 600M 591M 624M 642M 624M 619M
Weighted Average Basic & Diluted Shares Outstanding
670.60M 623.50M 615.10M 620M 589.03M 579.94M 580.06M 640.77M 626.15M 620.23M 602.43M
Cash Dividends to Common per Share
$4.60 $0.30 $0.30 $0.30 $12.40 $0.50 $0.50 $0.50 $0.50 $0.50 $0.50

Quarterly Income Statements for NortonLifeLock

This table shows NortonLifeLock's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026 Q4 2026
Period end date 9/29/2023 12/29/2023 3/29/2024 6/28/2024 9/27/2024 12/27/2024 3/28/2025 7/4/2025 10/3/2025 1/2/2026 4/3/2026
Net Income / (Loss) Attributable to Common Shareholders
147 142 134 181 161 159 142 135 134 192 512
Consolidated Net Income / (Loss)
147 142 134 181 161 159 142 135 134 192 512
Net Income / (Loss) Continuing Operations
147 142 134 181 161 159 142 135 134 192 512
Total Pre-Tax Income
-144 178 215 276 258 208 287 300 233 309 669
Total Operating Income
22 332 400 417 402 374 417 446 438 433 803
Total Gross Profit
765 766 777 775 780 793 811 990 954 972 1,007
Total Revenue
945 948 967 965 974 986 1,010 1,257 1,220 1,240 1,283
Operating Revenue
945 948 967 965 974 986 1,010 1,257 1,220 1,240 1,283
Total Cost of Revenue
180 182 190 190 194 193 199 267 266 268 276
Operating Cost of Revenue
180 182 190 190 194 193 199 267 266 268 276
Total Operating Expenses
743 434 377 358 378 419 394 544 516 539 204
Selling, General & Admin Expense
393 110 45 52 64 108 67 74 60 70 -291
Marketing Expense
187 184 181 183 184 182 196 297 297 307 327
Research & Development Expense
85 77 80 81 83 84 81 109 100 96 104
Amortization Expense
61 61 50 43 44 43 44 54 55 55 54
Restructuring Charge
17 2.00 21 -1.00 3.00 2.00 3.00 10 4.00 11 10
Total Other Income / (Expense), net
-166 -154 -185 -141 -144 -166 -130 -146 -205 -124 -134
Interest Expense
173 165 161 153 149 141 135 156 146 137 130
Other Income / (Expense), net
7.00 11 -24 12 5.00 -25 5.00 10 -59 13 -4.00
Income Tax Expense
-291 36 81 95 97 49 145 165 99 117 157
Basic Earnings per Share
$0.23 $0.22 $0.21 $0.29 $0.26 $0.26 $0.23 $0.22 $0.22 $0.31 $0.84
Weighted Average Basic Shares Outstanding
640M 639M 637M 621M 616M 616M 617M 617M 616M 611M 612M
Diluted Earnings per Share
$0.23 $0.22 $0.22 $0.29 $0.26 $0.26 $0.22 $0.22 $0.21 $0.31 $0.83
Weighted Average Diluted Shares Outstanding
644M 645M 642M 627M 622M 623M 624M 624M 624M 618M 619M
Weighted Average Basic & Diluted Shares Outstanding
640.72M 636.91M 626.15M 615.53M 616.20M 616.30M 620.23M 615.87M 616.72M 605.66M 602.43M

Annual Cash Flow Statements for NortonLifeLock

This table details how cash moves in and out of NortonLifeLock's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Period end date 4/1/2016 3/31/2017 3/30/2018 3/29/2019 4/3/2020 4/2/2021 4/1/2022 3/31/2023 3/29/2024 3/28/2025 4/3/2026
Net Change in Cash & Equivalents
3,109 -1,736 -2,473 45 386 -1,244 954 -1,137 96 160 -595
Net Cash From Operating Activities
802 -209 950 1,495 -861 706 974 757 2,064 1,221 1,545
Net Cash From Continuing Operating Activities
1,462 -145 950 1,495 -861 706 974 757 2,064 1,221 1,545
Net Income / (Loss) Continuing Operations
-821 -236 1,138 31 3,887 554 836 1,334 607 643 973
Consolidated Net Income / (Loss)
2,488 -106 1,138 31 3,887 554 836 1,334 607 643 973
Depreciation Expense
299 492 640 615 361 150 140 329 485 419 493
Non-Cash Adjustments To Reconcile Net Income
179 646 600 449 -5,731 127 -1.00 209 253 263 503
Changes in Operating Assets and Liabilities, net
1,805 -1,047 -1,428 400 622 -125 -1.00 -1,115 719 -104 -424
Net Cash From Investing Activities
7,173 -6,766 -21 -241 11,379 -69 326 -6,547 2.00 -100 -1,011
Net Cash From Continuing Investing Activities
7,236 -6,766 -21 -241 11,379 -69 326 -6,547 2.00 -100 -1,011
Purchase of Property, Plant & Equipment
-272 -70 -142 -207 -89 -6.00 -6.00 -6.00 -20 -15 -22
Acquisitions
-4.00 -6,736 -401 -180 0.00 -344 -39 -6,547 0.00 -84 -1,032
Purchase of Investments
-378 0.00 -436 - - - - 0.00 0.00 -4.00 0.00
Sale of Property, Plant & Equipment
- 0.00 0.00 26 0.00 218 355 0.00 25 0.00 21
Divestitures
6,535 7.00 933 0.00 11,298 - - - 0.00 0.00 40
Sale and/or Maturity of Investments
1,355 31 49 139 167 68 15 4.00 0.00 0.00 266
Other Investing Activities, net
0.00 2.00 -24 -19 3.00 -5.00 1.00 2.00 -3.00 3.00 -284
Net Cash From Financing Activities
-4,770 5,280 -3,475 -1,209 -10,123 -1,903 -333 4,681 -1,961 -970 -1,133
Net Cash From Continuing Financing Activities
-4,740 5,280 -3,475 -1,209 -10,123 -1,903 -333 4,681 -1,961 -970 -1,133
Repayment of Debt
-368 -97 -3,278 -604 -1,415 -1,942 -541 -3,047 -1,183 -1,311 -3,620
Repurchase of Common Equity
-1,868 -500 0.00 -234 -1,581 -304 0.00 -904 -441 -272 -634
Payment of Dividends
-3,030 -222 -211 -217 -7,481 -373 -303 -314 -323 -313 -312
Issuance of Debt
500 6,069 0.00 0.00 300 750 512 8,954 0.00 941 3,475
Issuance of Common Equity
65 95 121 19 123 24 14 12 12 11 13
Other Financing Activities, net
-39 -65 -107 -173 -69 -58 -15 -20 -26 -26 -55
Other Net Changes in Cash
- -41 73 - -9.00 - -13 -28 -9.00 - 4.00

Quarterly Cash Flow Statements for NortonLifeLock

This table details how cash moves in and out of NortonLifeLock's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026 Q4 2026
Period end date 9/29/2023 12/29/2023 3/29/2024 6/28/2024 9/27/2024 12/27/2024 3/28/2025 7/4/2025 10/3/2025 1/2/2026 4/3/2026
Net Change in Cash & Equivalents
6.00 -139 356 -202 93 146 123 -178 -127 -82 -208
Net Cash From Operating Activities
125 315 1,398 264 158 326 473 409 116 541 479
Net Cash From Continuing Operating Activities
125 315 1,398 264 158 326 473 409 116 541 479
Net Income / (Loss) Continuing Operations
147 142 134 181 161 159 142 135 134 192 512
Consolidated Net Income / (Loss)
147 142 134 181 161 159 142 135 134 192 512
Depreciation Expense
125 124 111 106 105 104 104 123 125 126 119
Non-Cash Adjustments To Reconcile Net Income
104 41 69 -24 50 96 85 156 155 59 133
Changes in Operating Assets and Liabilities, net
-251 8.00 1,084 1.00 -158 -33 142 -5.00 -298 164 -285
Net Cash From Investing Activities
9.00 1.00 -2.00 -2.00 -8.00 -7.00 -83 -873 -7.00 58 -189
Net Cash From Continuing Investing Activities
9.00 1.00 -2.00 -2.00 -8.00 -7.00 -83 -873 -7.00 58 -189
Purchase of Property, Plant & Equipment
-5.00 -8.00 -3.00 -2.00 -2.00 -8.00 -3.00 -4.00 -9.00 -6.00 -3.00
Acquisitions
- - - 0.00 - - - -876 - - -156
Sale and/or Maturity of Investments
- - - - - - - - - 9.00 253
Other Investing Activities, net
1.00 -3.00 1.00 0.00 -2.00 1.00 4.00 -2.00 -2.00 3.00 -283
Net Cash From Financing Activities
-135 -445 -1,031 -466 -72 -136 -296 290 -242 -682 -499
Net Cash From Continuing Financing Activities
-135 -445 -1,031 -466 -72 -136 -296 290 -242 -682 -499
Repayment of Debt
-58 -259 -658 -88 - -59 -1,164 -191 -169 -300 -2,960
Repurchase of Common Equity
- -100 -300 -272 - - - -134 - -300 -200
Payment of Dividends
-81 -81 -78 -82 -77 -77 -77 -82 -77 -77 -76
Issuance of Debt
- - - 0.00 - - - 741 - - 2,734
Issuance of Common Equity
- - 6.00 - - - 5.00 - - - 6.00
Other Financing Activities, net
-2.00 -5.00 -1.00 -24 -1.00 - -1.00 -44 -3.00 -5.00 -3.00
Other Net Changes in Cash
- - - 2.00 - - - - - - 1.00

Annual Balance Sheets for NortonLifeLock

This table presents NortonLifeLock's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Period end date 4/1/2016 3/31/2017 3/30/2018 3/29/2019 4/3/2020 4/2/2021 4/1/2022 3/31/2023 3/29/2024 3/28/2025 4/3/2026
Total Assets
11,767 18,174 15,759 15,938 7,735 6,361 6,943 15,947 15,793 15,495 15,589
Total Current Assets
6,959 5,324 3,493 3,186 3,079 1,538 2,260 1,233 1,358 1,444 1,081
Cash & Equivalents
5,983 4,247 1,774 1,791 2,177 933 1,887 750 846 1,006 411
Accounts Receivable
556 649 809 708 111 117 120 168 163 171 361
Other Current Assets
420 419 522 286 705 470 249 315 349 267 309
Plant, Property, & Equipment, net
957 937 778 663 238 78 60 76 72 60 71
Total Noncurrent Assets
3,851 11,913 11,488 12,089 4,418 4,745 4,623 14,638 14,363 13,991 14,437
Goodwill
3,148 8,627 8,319 2,677 2,585 2,867 2,873 10,217 10,210 10,237 10,996
Intangible Assets
443 3,004 2,643 1,202 1,067 1,116 1,023 3,097 2,638 2,267 2,096
Noncurrent Deferred & Refundable Income Taxes
- - - - - - - - - 1,218 1,153
Other Noncurrent Operating Assets
103 282 526 1,160 766 762 727 1,324 1,515 269 192
Total Liabilities & Shareholders' Equity
11,767 18,174 15,759 15,938 7,735 6,361 6,943 15,947 15,793 15,495 15,589
Total Liabilities
8,091 14,687 10,736 10,200 7,725 6,861 7,036 13,747 13,653 13,226 12,978
Total Current Liabilities
4,033 4,622 3,170 3,766 2,622 2,136 3,065 2,849 2,726 2,851 2,710
Short-Term Debt
0.00 1,310 0.00 491 756 313 1,000 233 175 291 181
Accounts Payable
175 180 168 165 87 52 63 77 66 94 96
Current Deferred Revenue
2,279 2,353 - - - - 1,264 1,708 1,808 1,846 1,904
Current Employee Benefit Liabilities
219 272 262 250 115 107 81 102 78 105 115
Other Current Liabilities
419 507 2,740 1,556 1,664 1,664 657 729 599 515 414
Total Noncurrent Liabilities
4,058 10,065 7,566 6,434 5,103 4,725 3,971 10,898 10,927 10,375 10,268
Long-Term Debt
2,207 6,876 5,026 3,961 3,465 3,288 2,736 9,529 8,429 7,968 8,015
Noncurrent Deferred Revenue
359 685 1,126 1,076 1,310 1,119 1,038 900 1,566 1,497 1,661
Noncurrent Deferred & Payable Income Tax Liabilities
1,395 2,401 592 577 149 137 75 395 261 222 198
Other Noncurrent Operating Liabilities
97 103 822 105 179 181 122 74 671 688 394
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
3,676 3,487 5,023 5,738 10 -500 -93 2,200 2,140 2,269 2,611
Total Preferred & Common Equity
3,676 3,487 5,023 5,738 10 -500 -93 2,200 2,140 2,269 2,611
Total Common Equity
3,676 3,487 5,023 5,738 10 -500 -93 2,200 2,140 2,269 2,611
Common Stock
4,309 4,236 4,691 4,812 3,356 2,229 1,851 2,800 2,227 2,066 2,341
Retained Earnings
-655 -761 328 933 -3,330 -2,776 -1,940 -585 -98 236 269
Accumulated Other Comprehensive Income / (Loss)
22 12 4.00 -7.00 -16 47 -4.00 -15 11 -33 1.00

Quarterly Balance Sheets for NortonLifeLock

This table presents NortonLifeLock's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026 Q2 2026 Q3 2026
Period end date 3/31/2023 6/30/2023 9/29/2023 12/29/2023 3/29/2024 6/28/2024 9/27/2024 12/27/2024 7/4/2025 10/3/2025 1/2/2026
Total Assets
15,947 15,787 16,411 16,282 15,793 15,428 15,471 15,363 16,360 16,051 15,831
Total Current Assets
1,233 1,087 1,076 1,720 1,358 1,111 1,222 1,320 1,428 1,289 1,253
Cash & Equivalents
750 623 629 490 846 644 737 883 828 701 619
Accounts Receivable
168 145 147 160 163 152 164 152 314 309 361
Other Current Assets
315 319 300 1,070 349 315 321 285 286 279 273
Plant, Property, & Equipment, net
76 73 75 76 72 69 60 61 64 68 69
Total Noncurrent Assets
14,638 14,627 15,260 14,486 14,363 14,248 14,189 13,982 14,868 14,694 14,509
Goodwill
10,217 10,241 10,199 10,231 10,210 10,205 10,235 10,171 10,817 10,829 10,847
Intangible Assets
3,097 2,982 2,859 2,745 2,638 2,537 2,442 2,336 2,499 2,377 2,212
Noncurrent Deferred & Refundable Income Taxes
- - - - - - - - 1,253 1,270 1,258
Other Noncurrent Operating Assets
1,324 1,404 2,202 1,510 1,515 1,506 1,512 1,475 299 218 192
Total Liabilities & Shareholders' Equity
15,947 15,787 16,411 16,282 15,793 15,428 15,471 15,363 16,360 16,051 15,831
Total Liabilities
13,747 13,450 13,997 13,864 13,653 13,458 13,373 13,212 13,995 13,594 13,499
Total Current Liabilities
2,849 2,748 2,460 2,563 2,726 3,752 3,822 3,764 2,858 2,552 2,688
Short-Term Debt
233 233 175 175 175 1,332 1,391 1,396 288 280 240
Accounts Payable
77 65 66 62 66 83 99 102 90 81 83
Current Deferred Revenue
1,708 1,631 1,599 1,666 1,808 1,745 1,749 1,777 1,783 1,768 1,822
Current Employee Benefit Liabilities
102 60 61 64 78 57 74 93 85 98 116
Other Current Liabilities
729 759 559 596 599 535 509 396 612 325 427
Total Noncurrent Liabilities
10,898 10,702 11,537 11,301 10,927 9,706 9,551 9,448 11,137 11,042 10,811
Long-Term Debt
9,529 9,327 9,333 9,081 8,429 7,190 7,137 7,080 8,575 8,421 8,167
Noncurrent Deferred Revenue
900 919 1,286 1,288 1,566 1,578 1,474 1,457 1,599 1,642 1,667
Noncurrent Deferred & Payable Income Tax Liabilities
395 385 256 265 261 253 248 223 234 229 220
Other Noncurrent Operating Liabilities
74 71 662 667 671 685 692 688 729 750 757
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
2,200 2,337 2,414 2,418 2,140 1,970 2,098 2,151 2,365 2,457 2,332
Total Preferred & Common Equity
2,200 2,337 2,414 2,418 2,140 1,970 2,098 2,151 2,365 2,457 2,332
Total Common Equity
2,200 2,337 2,414 2,418 2,140 1,970 2,098 2,151 2,365 2,457 2,332
Common Stock
2,800 2,697 2,655 2,502 2,227 1,959 1,995 2,026 2,179 2,236 2,281
Retained Earnings
-585 -396 -247 -103 -98 5.00 89 171 160 217 32
Accumulated Other Comprehensive Income / (Loss)
-15 36 6.00 19 11 6.00 14 -46 26 4.00 19

Annual Metrics And Ratios for NortonLifeLock

This table displays calculated financial ratios and metrics derived from NortonLifeLock's official financial filings.

Metric 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Period end date 4/1/2016 3/31/2017 3/30/2018 3/29/2019 4/3/2020 4/2/2021 4/1/2022 3/31/2023 3/29/2024 3/28/2025 4/3/2026
DEI Shares Outstanding
- - - - - - - - - - 605,663,774.00
DEI Adjusted Shares Outstanding
- - - - - - - - - - 605,663,774.00
DEI Earnings Per Adjusted Shares Outstanding
- - - - - - - - - - 1.61
Growth Metrics
- - - - - - - - - - -
Revenue Growth
-9.00% 11.64% -36.33% -4.03% 1.38% 2.45% 9.60% 19.38% 14.20% 3.55% 27.06%
EBITDA Growth
46.46% -42.82% 160.27% -37.19% 92.18% -15.26% 12.18% 17.28% 5.15% 26.55% 27.00%
EBIT Growth
177.98% -111.56% 1,025.93% -79.80% 904.95% 0.10% 14.96% 3.17% -6.39% 44.00% 29.43%
NOPAT Growth
-675.90% 92.69% -769.18% 118.18% 126.53% 185.45% 12.75% 155.33% -26.86% -33.26% 35.69%
Net Income Growth
183.37% -104.26% 1,173.58% -97.28% 12,438.71% -85.75% 50.90% 61.36% -54.34% 5.93% 51.32%
EPS Growth
194.44% -104.58% 1,100.00% -97.06% 12,000.00% -84.79% 53.26% 53.19% -55.56% 8.42% 52.43%
Operating Cash Flow Growth
-38.87% -126.06% 554.55% 57.37% -157.59% 182.00% 37.96% -22.28% 172.66% -40.84% 26.54%
Free Cash Flow Firm Growth
-55.65% -869.88% 86.07% 566.48% -75.16% -57.33% 125.88% -714.56% 137.33% -51.01% -64.46%
Invested Capital Growth
-115.06% 2,985.99% 6.34% -62.38% -33.67% 9.25% -18.51% 539.95% -11.21% -3.80% 9.18%
Revenue Q/Q Growth
52.48% 6.41% -46.00% 86.34% 27.76% 2.33% 1.60% 7.43% 0.53% 0.87% 5.78%
EBITDA Q/Q Growth
290.82% -35.11% -1.89% 56.33% 12.14% 0.00% -13.38% 24.21% 1.83% 1.50% 17.97%
EBIT Q/Q Growth
319.25% -121.86% -7.58% 165.58% 33.20% 1.70% -14.43% 20.50% 4.06% 2.36% 22.14%
NOPAT Q/Q Growth
-518.70% 96.77% -13.57% 275.56% -15.91% 39.92% -5.63% 173.78% -59.24% -5.36% 47.40%
Net Income Q/Q Growth
301.94% -105.09% 7.97% 150.00% 5.34% -6.26% -8.13% 143.50% -55.91% 0.31% 61.36%
EPS Q/Q Growth
312.22% -105.45% 10.39% 162.50% 5.77% -7.07% -7.84% 140.00% -56.36% 0.00% 63.54%
Operating Cash Flow Q/Q Growth
-22.44% 32.14% -8.57% 23.15% -159.30% 149.86% -2.99% -0.26% 108.48% -43.10% 0.39%
Free Cash Flow Firm Q/Q Growth
-55.56% -36.53% 62.33% 767.19% -84.91% 146.81% 29.44% 5.67% -10.08% -44.78% -10.72%
Invested Capital Q/Q Growth
-113.91% 38.53% 2.68% -64.56% 404.62% 5.39% -10.79% 6.15% -10.99% -2.28% 2.73%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
82.92% 78.78% 81.91% 81.47% 84.22% 85.81% 85.41% 82.35% 80.82% 80.28% 78.46%
EBITDA Margin
21.28% 10.90% 44.55% 29.15% 55.26% 45.71% 46.78% 45.96% 42.31% 51.49% 51.46%
Operating Margin
12.69% -2.49% -6.02% 6.43% 14.26% 35.12% 35.94% 36.76% 29.43% 40.91% 42.40%
EBIT Margin
12.97% -1.34% 19.54% 4.11% 40.76% 39.83% 41.77% 36.10% 29.59% 40.84% 41.60%
Profit (Net Income) Margin
69.11% -2.64% 44.47% 1.26% 156.10% 21.72% 29.90% 40.41% 16.16% 16.34% 19.46%
Tax Burden Percent
634.69% 40.46% 466.39% -28.97% 474.60% 63.53% 80.23% 167.79% 134.20% 62.49% 64.39%
Interest Burden Percent
83.94% 485.19% 48.80% -105.94% 80.69% 85.83% 89.21% 66.72% 40.69% 64.03% 72.64%
Effective Tax Rate
309.44% 0.00% -295.08% 0.00% 29.43% 20.18% 19.77% -67.79% -34.20% 37.51% 35.61%
Return on Invested Capital (ROIC)
-132.11% -1.96% -7.95% 2.04% 10.15% 34.73% 41.33% 31.76% 14.23% 10.36% 13.71%
ROIC Less NNEP Spread (ROIC-NNEP)
-216.53% 2,398.04% 43.46% -169.14% -884.43% 27.74% 42.65% 18.69% 3.62% 5.52% 8.49%
Return on Net Nonoperating Assets (RNNOA)
183.88% -1.00% 34.70% -1.46% 125.09% -260.86% -323.28% 96.29% 13.79% 18.81% 26.17%
Return on Equity (ROE)
51.77% -2.96% 26.75% 0.58% 135.25% -226.12% -281.96% 128.05% 28.02% 29.17% 39.88%
Cash Return on Invested Capital (CROIC)
0.00% -104.41% -14.09% 92.70% 50.64% 25.89% 61.73% -114.18% 26.10% 14.23% 4.93%
Operating Return on Assets (OROA)
3.74% -0.36% 2.95% 0.64% 8.58% 14.42% 17.56% 10.53% 7.11% 10.27% 13.38%
Return on Assets (ROA)
19.90% -0.71% 6.71% 0.20% 32.84% 7.86% 12.57% 11.79% 3.88% 4.11% 6.26%
Return on Common Equity (ROCE)
51.77% -2.96% 26.75% 0.58% 135.25% -226.12% -281.96% 128.05% 28.02% 29.17% 39.88%
Return on Equity Simple (ROE_SIMPLE)
67.68% -3.04% 22.66% 0.54% 0.00% -110.80% -898.92% 61.32% 28.04% 28.34% 0.00%
Net Operating Profit after Tax (NOPAT)
-957 -70 -608 111 251 715 806 2,059 1,506 1,006 1,365
NOPAT Margin
-26.59% -1.74% -23.78% 4.50% 10.06% 28.03% 28.84% 61.68% 39.50% 25.57% 27.30%
Net Nonoperating Expense Percent (NNEP)
84.42% -2,400.00% -51.41% 171.18% 894.58% 6.99% -1.32% 13.07% 10.61% 4.84% 5.22%
Return On Investment Capital (ROIC_SIMPLE)
- - - - - - - - - 9.56% 12.63%
Cost of Revenue to Revenue
17.08% 21.22% 18.09% 18.53% 15.78% 14.19% 14.59% 17.65% 19.18% 19.72% 21.54%
SG&A Expenses to Revenue
8.19% 14.03% 19.03% 16.69% 14.78% 8.43% 14.02% 8.57% 15.84% 7.40% -1.74%
R&D to Revenue
20.78% 20.48% 17.78% 17.10% 13.17% 10.47% 9.05% 9.38% 8.71% 8.36% 8.18%
Operating Expenses to Revenue
70.22% 81.26% 87.93% 75.04% 69.96% 50.69% 49.46% 45.60% 51.39% 39.36% 36.06%
Earnings before Interest and Taxes (EBIT)
467 -54 500 101 1,015 1,016 1,168 1,205 1,128 1,607 2,080
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
766 438 1,140 716 1,376 1,166 1,308 1,534 1,613 2,026 2,573
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
1.62 2.74 1.63 1.32 998.13 0.00 0.00 4.83 6.46 7.18 4.36
Price to Tangible Book Value (P/TBV)
70.14 0.00 0.00 4.08 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Price to Revenue (P/Rev)
1.66 2.38 3.19 3.09 4.01 4.55 5.32 3.19 3.72 4.14 2.28
Price to Earnings (P/E)
2.40 0.00 7.18 244.44 2.57 20.95 17.79 7.88 23.05 25.33 11.70
Dividend Yield
50.32% 27.85% 2.28% 2.53% 74.59% 2.51% 1.96% 3.01% 2.24% 1.89% 2.66%
Earnings Yield
41.73% 0.00% 13.93% 0.41% 38.94% 4.77% 5.62% 12.69% 4.34% 3.95% 8.55%
Enterprise Value to Invested Capital (EV/IC)
0.00 1.82 1.40 3.37 6.07 6.63 9.54 1.75 2.21 2.47 1.84
Enterprise Value to Revenue (EV/Rev)
0.56 3.36 4.31 4.07 4.79 5.59 5.98 5.89 5.76 5.98 3.83
Enterprise Value to EBITDA (EV/EBITDA)
2.65 30.78 9.68 13.95 8.68 12.23 12.78 12.81 13.61 11.62 7.45
Enterprise Value to EBIT (EV/EBIT)
4.34 0.00 22.07 98.88 11.76 14.03 14.31 16.30 19.46 14.65 9.21
Enterprise Value to NOPAT (EV/NOPAT)
0.00 0.00 0.00 90.30 47.65 19.93 20.73 9.54 14.58 23.40 14.04
Enterprise Value to Operating Cash Flow (EV/OCF)
2.53 0.00 11.62 6.68 0.00 20.19 17.16 25.95 10.64 19.28 12.40
Enterprise Value to Free Cash Flow (EV/FCFF)
2.02 0.00 0.00 1.99 9.56 26.74 13.88 0.00 7.95 17.03 39.02
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.60 2.35 1.00 0.78 422.10 -7.20 -40.17 4.44 3.92 3.64 3.14
Long-Term Debt to Equity
0.60 1.97 1.00 0.69 346.50 -6.58 -29.42 4.33 3.84 3.51 3.07
Financial Leverage
-0.85 0.00 0.80 0.01 -0.14 -9.40 -7.58 5.15 3.81 3.40 3.08
Leverage Ratio
2.60 4.18 3.99 2.95 4.12 -28.77 -22.44 10.86 7.21 7.10 6.37
Compound Leverage Factor
2.18 20.28 1.95 -3.12 3.32 -24.69 -20.01 7.25 2.94 4.54 4.63
Debt to Total Capital
37.51% 70.13% 50.01% 43.69% 99.76% 116.12% 102.55% 81.61% 79.66% 78.45% 75.84%
Short-Term Debt to Total Capital
0.00% 11.22% 0.00% 4.82% 17.87% 10.09% 27.45% 1.95% 1.62% 2.76% 1.67%
Long-Term Debt to Total Capital
37.51% 58.91% 50.01% 38.87% 81.90% 106.03% 75.10% 79.66% 78.04% 75.68% 74.16%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
62.49% 29.87% 49.99% 56.31% 0.24% -16.12% -2.55% 18.39% 20.34% 21.55% 24.16%
Debt to EBITDA
2.88 18.69 4.41 6.22 3.07 3.09 2.86 6.36 5.33 4.08 3.19
Net Debt to EBITDA
-5.13 8.97 2.51 3.36 1.42 2.27 1.41 5.87 4.81 3.58 3.03
Long-Term Debt to EBITDA
2.88 15.70 4.41 5.53 2.52 2.82 2.09 6.21 5.23 3.93 3.12
Debt to NOPAT
-2.31 -116.94 -8.26 40.25 16.85 5.04 4.63 4.74 5.71 8.21 6.00
Net Debt to NOPAT
4.11 -56.14 -4.71 21.78 7.82 3.71 2.29 4.38 5.15 7.21 5.70
Long-Term Debt to NOPAT
-2.31 -98.23 -8.26 35.81 13.83 4.60 3.39 4.63 5.60 7.92 5.87
Altman Z-Score
1.10 0.59 0.78 0.66 1.00 1.22 1.70 0.75 1.00 1.25 1.19
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
1.73 1.15 1.10 0.85 1.17 0.72 0.74 0.43 0.51 0.51 0.40
Quick Ratio
1.62 1.06 0.94 0.73 0.91 0.50 0.66 0.32 0.38 0.41 0.28
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
1,006 -7,744 -1,078 5,031 1,250 533 1,204 -7,401 2,763 1,382 491
Operating Cash Flow to CapEx
294.85% -298.57% 669.01% 825.97% -967.42% 0.00% 0.00% 12,616.67% 0.00% 8,140.00% 154,500.00%
Free Cash Flow to Firm to Interest Expense
13.41 -37.23 -4.21 24.19 6.38 3.70 9.56 -18.46 4.13 2.39 0.86
Operating Cash Flow to Interest Expense
10.69 -1.00 3.71 7.19 -4.39 4.90 7.73 1.89 3.09 2.11 2.72
Operating Cash Flow Less CapEx to Interest Expense
7.07 -1.34 3.16 6.32 -4.85 6.38 10.50 1.87 3.09 2.09 2.71
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.29 0.27 0.15 0.16 0.21 0.36 0.42 0.29 0.24 0.25 0.32
Accounts Receivable Turnover
5.73 6.67 3.51 3.24 6.08 22.38 23.59 23.18 23.03 23.56 18.80
Inventory Turnover
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
3.78 4.24 2.98 3.41 5.53 16.15 40.52 49.09 51.51 59.62 76.34
Accounts Payable Turnover
3.58 4.81 2.66 2.73 3.12 5.21 7.10 8.41 10.22 9.70 11.34
Days Sales Outstanding (DSO)
63.67 54.72 103.98 112.73 60.03 16.31 15.47 15.75 15.85 15.49 19.42
Days Inventory Outstanding (DIO)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)
102.08 75.95 137.17 133.57 117.02 70.08 51.44 43.38 35.70 37.63 32.20
Cash Conversion Cycle (CCC)
-38.41 -21.23 -33.19 -20.84 -57.00 -53.76 -35.97 -27.63 -19.85 -22.14 -12.78
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
-257 7,417 7,887 2,967 1,968 2,150 1,752 11,212 9,955 9,522 10,396
Invested Capital Turnover
4.97 1.12 0.33 0.45 1.01 1.24 1.43 0.52 0.36 0.41 0.50
Increase / (Decrease) in Invested Capital
-1,963 7,674 470 -4,920 -999 182 -398 9,460 -1,257 -376 874
Enterprise Value (EV)
2,029 13,484 11,035 9,987 11,939 14,254 16,715 19,645 21,955 23,542 19,165
Market Capitalization
5,962 9,554 8,171 7,578 9,981 11,604 14,870 10,633 14,197 16,289 11,380
Book Value per Share
$5.64 $5.63 $8.08 $8.98 $0.02 ($0.86) ($0.16) $3.44 $3.45 $3.68 $4.31
Tangible Book Value per Share
$0.13 ($13.16) ($9.56) $2.91 ($6.07) ($7.70) ($6.86) ($17.39) ($16.72) ($16.61) ($17.31)
Total Capital
5,883 11,673 10,049 10,190 4,231 3,101 3,643 11,962 10,801 10,528 10,807
Total Debt
2,207 8,186 5,026 4,452 4,221 3,601 3,736 9,762 8,604 8,259 8,196
Total Long-Term Debt
2,207 6,876 5,026 3,961 3,465 3,288 2,736 9,529 8,429 7,968 8,015
Net Debt
-3,933 3,930 2,864 2,409 1,958 2,650 1,845 9,012 7,758 7,253 7,785
Capital Expenditures (CapEx)
272 70 142 181 89 -212 -349 6.00 -5.00 15 1.00
Debt-free, Cash-free Net Working Capital (DFCFNWC)
-3,057 -2,244 -1,839 -2,132 -1,050 -1,236 -1,696 -2,133 -1,961 -2,122 -1,859
Debt-free Net Working Capital (DFNWC)
2,926 2,012 323 -89 1,213 -285 195 -1,383 -1,115 -1,116 -1,448
Net Working Capital (NWC)
2,926 702 323 -580 457 -598 -805 -1,616 -1,290 -1,407 -1,629
Net Nonoperating Expense (NNE)
-3,445 36 -1,746 80 -3,636 161 -30 710 890 363 392
Net Nonoperating Obligations (NNO)
-3,933 3,930 2,864 -2,771 1,958 2,650 1,845 9,012 7,758 7,253 7,785
Total Depreciation and Amortization (D&A)
299 492 640 615 361 150 140 329 485 419 493
Debt-free, Cash-free Net Working Capital to Revenue
-84.92% -55.83% -71.86% -86.81% -42.17% -48.45% -60.66% -63.90% -51.44% -53.93% -37.18%
Debt-free Net Working Capital to Revenue
81.28% 50.06% 12.62% -3.62% 48.71% -11.17% 6.97% -41.43% -29.25% -28.36% -28.96%
Net Working Capital to Revenue
81.28% 17.47% 12.62% -23.62% 18.35% -23.44% -28.79% -48.41% -33.84% -35.76% -32.58%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$3.71 ($0.17) $1.85 $0.05 $6.32 $0.94 $1.44 $2.20 $0.97 $1.04 $1.59
Adjusted Weighted Average Basic Shares Outstanding
670M 618M 616M 632M 615M 589M 581M 614M 637M 617M 612M
Adjusted Diluted Earnings per Share
$3.71 ($0.17) $1.70 $0.05 $6.05 $0.92 $1.41 $2.16 $0.96 $1.03 $1.57
Adjusted Weighted Average Diluted Shares Outstanding
670M 618M 668M 661M 643M 600M 591M 624M 642M 624M 619M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.05 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
612.29M 608.24M 615.10M 618.19M 589.03M 579.94M 580.06M 640.77M 626.15M 620.23M 602.43M
Normalized Net Operating Profit after Tax (NOPAT)
415 121 158 265 438 844 831 907 825 1,012 1,388
Normalized NOPAT Margin
11.53% 3.01% 6.18% 10.80% 17.60% 33.07% 29.73% 27.18% 21.65% 25.73% 27.75%
Pre Tax Income Margin
10.89% -6.52% 9.54% -4.36% 32.89% 34.18% 37.27% 24.09% 12.04% 26.15% 30.22%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
6.23 -0.26 1.95 0.49 5.18 7.06 9.27 3.01 1.69 2.78 3.66
NOPAT to Interest Expense
-12.76 -0.34 -2.38 0.53 1.28 4.97 6.40 5.13 2.25 1.74 2.40
EBIT Less CapEx to Interest Expense
2.60 -0.60 1.40 -0.38 4.72 8.53 12.04 2.99 1.69 2.75 3.65
NOPAT Less CapEx to Interest Expense
-16.39 -0.67 -2.93 -0.34 0.82 6.44 9.17 5.12 2.26 1.71 2.40
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
121.78% -209.43% 18.54% 700.00% 192.46% 67.33% 36.24% 23.28% 52.44% 48.68% 32.07%
Augmented Payout Ratio
196.87% -681.13% 18.54% 1,454.84% 233.14% 122.20% 36.24% 90.29% 124.03% 90.98% 97.23%

Quarterly Metrics And Ratios for NortonLifeLock

This table displays calculated financial ratios and metrics derived from NortonLifeLock's official financial filings.

Metric Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026 Q4 2026
Period end date 9/29/2023 12/29/2023 3/29/2024 6/28/2024 9/27/2024 12/27/2024 3/28/2025 7/4/2025 10/3/2025 1/2/2026 4/3/2026
DEI Shares Outstanding
- - - - - - - - - - 605,663,774.00
DEI Adjusted Shares Outstanding
- - - - - - - - - - 605,663,774.00
DEI Earnings Per Adjusted Shares Outstanding
- - - - - - - - - - 0.85
Growth Metrics
- - - - - - - - - - -
Revenue Growth
26.34% 1.28% 2.11% 2.33% 3.07% 4.01% 4.77% 30.26% 25.26% 25.76% 27.03%
EBITDA Growth
-47.26% -5.66% 6.33% 7.86% 232.47% -3.00% 8.68% 8.22% -1.56% 26.27% 74.52%
EBIT Growth
-88.07% -7.30% 13.25% 15.63% 1,303.45% 1.75% 13.14% 6.29% -6.88% 27.79% 89.34%
NOPAT Growth
-81.94% -5.78% -87.48% -18.12% 1,528.96% 7.94% -15.90% -26.61% 0.41% -5.89% 197.86%
Net Income Growth
113.04% -13.94% -85.36% -3.21% 9.52% 11.97% 8.40% -25.41% -16.77% 20.75% 260.56%
EPS Growth
91.67% -12.00% -84.93% 0.00% 13.04% 18.18% 4.76% -24.14% -19.23% 19.23% 277.27%
Operating Cash Flow Growth
242.05% 2.94% 331.48% 16.81% 26.40% 3.49% -66.17% 54.92% -26.58% 65.95% 1.27%
Free Cash Flow Firm Growth
92.74% 95.71% 120.17% 118.47% 368.38% 583.25% -62.66% -120.67% -119.10% -106.20% -144.55%
Invested Capital Growth
5.93% 5.89% -11.21% -12.65% -12.43% -12.88% -3.80% 5.61% 5.74% 3.86% 9.18%
Revenue Q/Q Growth
0.21% 0.32% 1.68% -0.21% 0.93% 1.23% 2.43% 24.46% -2.94% 1.64% 3.47%
EBITDA Q/Q Growth
-68.95% 203.25% 3.62% 9.86% -4.30% -11.52% 16.11% 10.08% -12.95% 13.49% 60.49%
EBIT Q/Q Growth
-92.18% 1,082.76% 8.67% 14.10% -5.13% -14.25% 20.92% 8.06% -16.89% 17.68% 79.15%
NOPAT Q/Q Growth
-95.39% 1,619.83% -6.46% 9.69% -8.27% 13.97% -27.83% -2.72% 25.51% 6.81% 128.42%
Net Income Q/Q Growth
-21.39% -3.40% -6.94% 35.07% -11.05% -1.24% -10.69% -4.93% -0.74% 43.28% 166.67%
EPS Q/Q Growth
-20.69% -4.35% 0.00% 31.82% -10.34% 0.00% -15.38% 0.00% -4.55% 47.62% 167.74%
Operating Cash Flow Q/Q Growth
-44.69% 152.00% 343.81% -81.12% -40.15% 106.33% 45.09% -13.53% -71.64% 366.38% -11.46%
Free Cash Flow Firm Q/Q Growth
93.30% 42.08% 523.74% 12.82% -2.62% 4.29% -66.26% -160.33% 10.02% 66.17% -142.58%
Invested Capital Q/Q Growth
0.17% -0.97% -10.99% -1.07% 0.42% -1.47% -2.28% 9.22% 0.55% -3.22% 2.73%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
80.95% 80.80% 80.35% 80.31% 80.08% 80.43% 80.30% 78.76% 78.20% 78.39% 78.49%
EBITDA Margin
16.30% 49.26% 50.36% 55.44% 52.57% 45.94% 52.08% 46.06% 41.31% 46.13% 71.55%
Operating Margin
2.33% 35.02% 41.37% 43.21% 41.27% 37.93% 41.29% 35.48% 35.90% 34.92% 62.59%
EBIT Margin
3.07% 36.18% 38.88% 44.46% 41.79% 35.40% 41.78% 36.28% 31.07% 35.97% 62.28%
Profit (Net Income) Margin
15.56% 14.98% 13.86% 18.76% 16.53% 16.13% 14.06% 10.74% 10.98% 15.48% 39.91%
Tax Burden Percent
-102.08% 79.78% 62.33% 65.58% 62.40% 76.44% 49.48% 45.00% 57.51% 62.14% 76.53%
Interest Burden Percent
-496.55% 51.90% 57.18% 64.34% 63.39% 59.60% 68.01% 65.79% 61.48% 69.28% 83.73%
Effective Tax Rate
0.00% 20.22% 37.67% 34.42% 37.60% 23.56% 50.52% 55.00% 42.49% 37.86% 23.47%
Return on Invested Capital (ROIC)
0.56% 9.72% 9.29% 10.29% 9.39% 10.81% 8.28% 6.67% 9.08% 10.33% 24.05%
ROIC Less NNEP Spread (ROIC-NNEP)
2.04% 8.36% 7.91% 9.19% 8.32% 9.26% 7.42% 5.84% 7.59% 9.32% 22.68%
Return on Net Nonoperating Assets (RNNOA)
8.83% 40.39% 30.17% 35.87% 30.72% 33.15% 25.27% 21.44% 26.30% 31.99% 69.90%
Return on Equity (ROE)
9.39% 50.11% 39.46% 46.16% 40.12% 43.96% 33.55% 28.11% 35.37% 42.32% 93.95%
Cash Return on Invested Capital (CROIC)
26.84% 28.59% 26.10% 26.27% 23.08% 23.92% 14.23% 3.73% 3.55% 5.54% 4.93%
Operating Return on Assets (OROA)
0.72% 8.61% 9.35% 10.92% 10.13% 8.73% 10.51% 9.65% 8.82% 10.90% 20.03%
Return on Assets (ROA)
3.63% 3.57% 3.33% 4.61% 4.01% 3.98% 3.54% 2.86% 3.12% 4.69% 12.84%
Return on Common Equity (ROCE)
9.39% 50.11% 39.46% 46.16% 40.12% 43.96% 33.55% 28.11% 35.37% 42.32% 93.95%
Return on Equity Simple (ROE_SIMPLE)
58.58% 57.53% 0.00% 30.96% 29.74% 29.80% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)
15 265 249 273 251 286 206 201 252 269 615
NOPAT Margin
1.63% 27.94% 25.78% 28.34% 25.76% 29.00% 20.43% 15.97% 20.65% 21.70% 47.90%
Net Nonoperating Expense Percent (NNEP)
-1.48% 1.36% 1.38% 1.10% 1.08% 1.55% 0.86% 0.83% 1.49% 1.00% 1.36%
Return On Investment Capital (ROIC_SIMPLE)
- 2.27% - - - 2.69% 1.96% 1.79% 2.26% 2.51% 5.69%
Cost of Revenue to Revenue
19.05% 19.20% 19.65% 19.69% 19.92% 19.57% 19.70% 21.24% 21.80% 21.61% 21.51%
SG&A Expenses to Revenue
41.59% 11.60% 4.65% 5.39% 6.57% 10.95% 6.63% 5.89% 4.92% 5.65% -22.68%
R&D to Revenue
8.99% 8.12% 8.27% 8.39% 8.52% 8.52% 8.02% 8.67% 8.20% 7.74% 8.11%
Operating Expenses to Revenue
78.62% 45.78% 38.99% 37.10% 38.81% 42.49% 39.01% 43.28% 42.30% 43.47% 15.90%
Earnings before Interest and Taxes (EBIT)
29 343 376 429 407 349 422 456 379 446 799
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
154 467 487 535 512 453 526 579 504 572 918
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
4.58 5.93 6.46 7.94 8.06 7.92 7.18 8.00 6.97 6.89 4.36
Price to Tangible Book Value (P/TBV)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Price to Revenue (P/Rev)
2.93 3.79 3.72 4.08 4.38 4.37 4.14 4.47 3.83 3.40 2.28
Price to Earnings (P/E)
7.82 10.30 23.05 25.64 27.10 26.58 25.33 31.68 30.06 26.66 11.70
Dividend Yield
2.89% 2.24% 2.24% 2.00% 1.82% 1.81% 1.89% 1.64% 1.80% 1.92% 2.66%
Earnings Yield
12.78% 9.71% 4.34% 3.90% 3.69% 3.76% 3.95% 3.16% 3.33% 3.75% 8.55%
Enterprise Value to Invested Capital (EV/IC)
1.77 2.07 2.21 2.39 2.50 2.53 2.47 2.59 2.40 2.36 1.84
Enterprise Value to Revenue (EV/Rev)
5.29 6.11 5.76 6.13 6.39 6.31 5.98 6.37 5.62 5.05 3.83
Enterprise Value to EBITDA (EV/EBITDA)
12.44 14.67 13.61 14.24 12.29 12.34 11.62 13.02 12.19 10.94 7.45
Enterprise Value to EBIT (EV/EBIT)
18.09 21.49 19.46 19.83 15.79 15.69 14.65 16.49 15.65 14.01 9.21
Enterprise Value to NOPAT (EV/NOPAT)
5.57 6.19 14.58 17.45 23.75 23.17 23.40 29.00 27.06 25.77 14.04
Enterprise Value to Operating Cash Flow (EV/OCF)
20.33 23.33 10.64 11.19 11.57 11.48 19.28 19.73 18.98 15.51 12.40
Enterprise Value to Free Cash Flow (EV/FCFF)
6.77 7.43 7.95 8.48 10.11 9.84 17.03 71.43 69.67 43.38 39.02
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
3.94 3.83 3.92 4.33 4.06 3.94 3.64 3.75 3.54 3.61 3.14
Long-Term Debt to Equity
3.87 3.76 3.84 3.65 3.40 3.29 3.51 3.63 3.43 3.50 3.07
Financial Leverage
4.34 4.83 3.81 3.90 3.69 3.58 3.40 3.67 3.47 3.43 3.08
Leverage Ratio
7.85 8.53 7.21 7.25 7.07 6.93 7.10 7.33 6.92 6.96 6.37
Compound Leverage Factor
-39.00 4.42 4.12 4.66 4.48 4.13 4.83 4.82 4.25 4.82 5.33
Debt to Total Capital
79.75% 79.29% 79.66% 81.22% 80.26% 79.76% 78.45% 78.94% 77.98% 78.28% 75.84%
Short-Term Debt to Total Capital
1.47% 1.50% 1.62% 12.70% 13.09% 13.14% 2.76% 2.57% 2.51% 2.23% 1.67%
Long-Term Debt to Total Capital
78.28% 77.79% 78.04% 68.53% 67.17% 66.62% 75.68% 76.37% 75.47% 76.05% 74.16%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
20.25% 20.71% 20.34% 18.78% 19.74% 20.24% 21.55% 21.06% 22.02% 21.72% 24.16%
Debt to EBITDA
5.93 5.88 5.33 5.16 4.24 4.25 4.08 4.28 4.22 3.85 3.19
Net Debt to EBITDA
5.54 5.57 4.81 4.77 3.88 3.80 3.58 3.88 3.88 3.57 3.03
Long-Term Debt to EBITDA
5.82 5.77 5.23 4.35 3.55 3.55 3.93 4.14 4.08 3.74 3.12
Debt to NOPAT
2.66 2.48 5.71 6.32 8.20 7.97 8.21 9.54 9.37 9.08 6.00
Net Debt to NOPAT
2.48 2.35 5.15 5.84 7.49 7.14 7.21 8.65 8.61 8.41 5.70
Long-Term Debt to NOPAT
2.61 2.43 5.60 5.33 6.86 6.66 7.92 9.23 9.07 8.82 5.87
Altman Z-Score
0.59 0.85 0.85 0.83 0.90 0.93 1.00 1.07 1.04 1.00 0.91
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
0.44 0.67 0.51 0.30 0.32 0.35 0.51 0.50 0.51 0.47 0.40
Quick Ratio
0.32 0.25 0.38 0.21 0.24 0.28 0.41 0.40 0.40 0.36 0.28
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
-617 -357 1,506 1,699 1,655 1,726 582 -351 -316 -107 -259
Operating Cash Flow to CapEx
2,500.00% 0.00% 46,600.00% 13,200.00% 7,900.00% 4,075.00% 15,766.67% 0.00% 1,288.89% 0.00% 15,966.67%
Free Cash Flow to Firm to Interest Expense
-3.56 -2.16 9.36 11.11 11.11 12.24 4.31 -2.25 -2.17 -0.78 -2.00
Operating Cash Flow to Interest Expense
0.72 1.91 8.68 1.73 1.06 2.31 3.50 2.62 0.79 3.95 3.68
Operating Cash Flow Less CapEx to Interest Expense
0.69 1.93 8.66 1.71 1.05 2.26 3.48 2.65 0.73 3.99 3.66
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.23 0.24 0.24 0.25 0.24 0.25 0.25 0.27 0.28 0.30 0.32
Accounts Receivable Turnover
25.22 23.07 23.03 25.82 24.84 25.01 23.56 18.14 18.91 18.43 18.80
Inventory Turnover
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
41.21 42.03 51.51 54.00 57.23 56.95 59.62 63.56 69.89 72.72 76.34
Accounts Payable Turnover
11.02 10.67 10.22 10.03 9.16 9.35 9.70 9.86 10.28 10.81 11.34
Days Sales Outstanding (DSO)
14.47 15.82 15.85 14.14 14.69 14.60 15.49 20.12 19.30 19.81 19.42
Days Inventory Outstanding (DIO)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)
33.14 34.20 35.70 36.40 39.83 39.02 37.63 37.01 35.51 33.76 32.20
Cash Conversion Cycle (CCC)
-18.67 -18.38 -19.85 -22.26 -25.14 -24.43 -22.14 -16.89 -16.21 -13.96 -12.78
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
11,293 11,184 9,955 9,848 9,889 9,744 9,522 10,400 10,457 10,120 10,396
Invested Capital Turnover
0.34 0.35 0.36 0.36 0.36 0.37 0.41 0.42 0.44 0.48 0.50
Increase / (Decrease) in Invested Capital
632 622 -1,257 -1,426 -1,404 -1,440 -376 552 568 376 874
Enterprise Value (EV)
19,939 23,098 21,955 23,519 24,699 24,631 23,542 26,946 25,133 23,866 19,165
Market Capitalization
11,060 14,332 14,197 15,641 16,908 17,038 16,289 18,911 17,133 16,078 11,380
Book Value per Share
$3.78 $3.77 $3.45 $3.15 $3.41 $3.49 $3.68 $3.81 $3.99 $3.78 $4.31
Tangible Book Value per Share
($16.65) ($16.48) ($16.72) ($17.20) ($17.19) ($16.81) ($16.61) ($17.66) ($17.45) ($17.39) ($17.31)
Total Capital
11,922 11,674 10,801 10,492 10,626 10,627 10,528 11,228 11,158 10,739 10,807
Total Debt
9,508 9,256 8,604 8,522 8,528 8,476 8,259 8,863 8,701 8,407 8,196
Total Long-Term Debt
9,333 9,081 8,429 7,190 7,137 7,080 7,968 8,575 8,421 8,167 8,015
Net Debt
8,879 8,766 7,758 7,878 7,791 7,593 7,253 8,035 8,000 7,788 7,785
Capital Expenditures (CapEx)
5.00 -4.00 3.00 2.00 2.00 8.00 3.00 -5.00 9.00 -6.00 3.00
Debt-free, Cash-free Net Working Capital (DFCFNWC)
-1,838 -1,158 -1,961 -1,953 -1,946 -1,931 -2,122 -1,970 -1,684 -1,814 -1,859
Debt-free Net Working Capital (DFNWC)
-1,209 -668 -1,115 -1,309 -1,209 -1,048 -1,116 -1,142 -983 -1,195 -1,448
Net Working Capital (NWC)
-1,384 -843 -1,290 -2,641 -2,600 -2,444 -1,407 -1,430 -1,263 -1,435 -1,629
Net Nonoperating Expense (NNE)
-132 123 115 92 90 127 64 66 118 77 103
Net Nonoperating Obligations (NNO)
8,879 8,766 7,758 7,878 7,791 7,593 7,253 8,035 8,000 7,788 7,785
Total Depreciation and Amortization (D&A)
125 124 111 106 105 104 104 123 125 126 119
Debt-free, Cash-free Net Working Capital to Revenue
-48.74% -30.61% -51.44% -50.94% -50.38% -49.50% -53.93% -46.61% -37.65% -38.38% -37.18%
Debt-free Net Working Capital to Revenue
-32.06% -17.66% -29.25% -34.14% -31.30% -26.86% -28.36% -27.02% -21.98% -25.28% -28.96%
Net Working Capital to Revenue
-36.70% -22.28% -33.84% -68.88% -67.31% -62.65% -35.76% -33.83% -28.24% -30.36% -32.58%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$0.23 $0.23 $0.21 $0.29 $0.26 $0.26 $0.23 $0.22 $0.22 $0.31 $0.84
Adjusted Weighted Average Basic Shares Outstanding
640M 639M 637M 621M 616M 616M 617M 617M 616M 611M 612M
Adjusted Diluted Earnings per Share
$0.23 $0.22 $0.22 $0.29 $0.26 $0.26 $0.22 $0.22 $0.21 $0.31 $0.83
Adjusted Weighted Average Diluted Shares Outstanding
644M 645M 642M 627M 622M 623M 624M 624M 624M 618M 619M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
640.72M 636.91M 626.15M 615.53M 616.20M 616.30M 620.23M 615.87M 616.72M 605.66M 602.43M
Normalized Net Operating Profit after Tax (NOPAT)
27 266 262 273 253 287 294 319 254 276 622
Normalized NOPAT Margin
2.89% 28.11% 27.13% 28.27% 25.95% 29.15% 29.11% 25.39% 20.84% 22.25% 48.50%
Pre Tax Income Margin
-15.24% 18.78% 22.23% 28.60% 26.49% 21.10% 28.42% 23.87% 19.10% 24.92% 52.14%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
0.17 2.08 2.34 2.80 2.73 2.48 3.13 2.92 2.60 3.26 6.15
NOPAT to Interest Expense
0.09 1.61 1.55 1.79 1.68 2.03 1.53 1.29 1.73 1.96 4.73
EBIT Less CapEx to Interest Expense
0.14 2.10 2.32 2.79 2.72 2.42 3.10 2.96 2.53 3.30 6.12
NOPAT Less CapEx to Interest Expense
0.06 1.63 1.53 1.77 1.67 1.97 1.51 1.32 1.66 2.01 4.70
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
22.98% 23.36% 52.44% 52.79% 50.96% 48.99% 48.68% 52.43% 54.91% 51.91% 32.07%
Augmented Payout Ratio
61.24% 33.50% 124.03% 162.95% 158.65% 138.22% 90.98% 74.87% 78.42% 123.88% 97.23%

Financials Breakdown Chart

Key Financial Trends

Gen Digital’s recent results show steady revenue growth, strong profitability, and consistently healthy operating cash flow, but the company is also carrying a large debt load and has been using cash for acquisitions and shareholder returns.

Over the last four years, Gen Digital has generally posted stable top-line performance with improving earnings quality. Revenue has climbed from roughly $943 million in Q1 2024 to $1.283 billion in Q4 2026, while quarterly net income has remained positive throughout the period. The company’s operating margins also look solid, with quarterly operating income of $803 million in Q4 2026 on revenue of $1.283 billion.

One of the most encouraging trends is cash generation. Gen Digital produced $479 million of operating cash flow in Q4 2026, after $541 million in Q3 2026 and $409 million in Q1 2026. That suggests the business continues to convert accounting profits into real cash. For a software/security company, that is an important positive signal.

At the same time, the balance sheet shows meaningful leverage. As of Q3 2026, total debt stood at about $8.41 billion in long-term debt plus $280 million in short-term debt, versus only $2.457 billion in equity. Debt has come down from the peak levels seen after earlier acquisition activity, but it remains a major factor investors should watch.

Another important point is the trend in equity and retained earnings. Common equity rose from just $2.098 billion in Q2 2025 to $2.457 billion in Q2 2026, helped by profits and capital actions. Retained earnings also improved sharply from $89 million in Q2 2025 to $217 million in Q2 2026 and $32 million in Q3 2026, though the fluctuations suggest the company is actively managing its capital structure and distributions.

Here are the key takeaways for investors:

  • Revenue is trending higher year over year, with Q4 2026 revenue up to $1.283 billion from $1.010 billion in Q4 2025.
  • Profitability remains strong, with quarterly net income staying solidly positive across the period.
  • Operating cash flow is robust, supporting dividends, debt reduction, and acquisitions.
  • Gross profit remains high, indicating strong underlying margins for the core business.
  • Q4 2026 debt repayment was significant, showing continued balance-sheet management.
  • Share count is relatively stable, so EPS changes are being driven mostly by earnings performance rather than major dilution.
  • Acquisition activity continues, which could support growth but also adds integration risk.
  • Dividend payments are ongoing, which may appeal to income-focused investors but also use cash that could otherwise reduce debt faster.
  • Debt remains elevated and interest expense is still a meaningful drag on pre-tax earnings.
  • Q4 2026 financing cash flow was negative, reflecting heavy debt repayment, buybacks, and dividends.

Overall, Gen Digital appears to be a cash-generative, profitable software company with improving operating performance. The main risk is the balance sheet: leverage is still high enough that interest expense and refinancing strategy matter. For retail investors, the stock looks like a business with solid fundamentals, but the debt burden keeps the story from being low-risk.

05/29/26 03:25 PM ETAI Generated. May Contain Errors.

NortonLifeLock Financials - Frequently Asked Questions

According to the most recent income statement we have on file, NortonLifeLock's fiscal year ends in April. Their fiscal year 2026 ended on April 3, 2026.

NortonLifeLock's net income appears to be on a downward trend, with a most recent value of $973 million in 2026, falling from $2.49 billion in 2016. The previous period was $643 million in 2025.

NortonLifeLock's total operating income in 2026 was $2.12 billion, based on the following breakdown:
  • Total Gross Profit: $3.92 billion
  • Total Operating Expenses: $1.80 billion

Over the last 10 years, NortonLifeLock's total revenue changed from $3.60 billion in 2016 to $5 billion in 2026, a change of 38.9%.

NortonLifeLock's total liabilities were at $12.98 billion at the end of 2026, a 1.9% decrease from 2025, and a 60.4% increase since 2016.

In the past 10 years, NortonLifeLock's cash and equivalents has ranged from $411 million in 2026 to $5.98 billion in 2016, and is currently $411 million as of their latest financial filing in 2026.

Over the last 10 years, NortonLifeLock's book value per share changed from 5.64 in 2016 to 4.31 in 2026, a change of -23.5%.



Financial statements for NASDAQ:NLOK last updated on 5/22/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners